Active Ingredient: MIRABEGRON
Proprietary Name: MYRBETRIQ GRANULES
Dosage Form; Route of Administration: FOR SUSPENSION, EXTENDED RELEASE; ORAL
Strength: 8MG/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N213801
Product Number: 001
Approval Date: Mar 25, 2021
Applicant Holder Full Name: ASTELLAS PHARMA GLOBAL DEVELOPMENT INC
Marketing Status:
Prescription
Patent and Exclusivity Information
